Tripex Pharmaceuticals Overview
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Tripex Pharmaceuticals General Information
Description
Developer of medicinal drugs designed to treat chronic pulmonary infections. The company's medicinal drugs offer an inhaled fluoroquinolone for the management of chronic pulmonary infections, enabling patients to access effective lungs infection treatment.
Contact Information
Corporate Office
- United States
Corporate Office
- United States
Tripex Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Secondary Transaction - Private | Completed | Startup | ||||
1. Early Stage VC | 30-Sep-2015 | Completed | Startup |
Tripex Pharmaceuticals FAQs
-
Where is Tripex Pharmaceuticals headquartered?
Tripex Pharmaceuticals is headquartered in .
-
What industry is Tripex Pharmaceuticals in?
Tripex Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Tripex Pharmaceuticals a private or public company?
Tripex Pharmaceuticals is a Private company.
-
What is Tripex Pharmaceuticals’s current revenue?
The current revenue for Tripex Pharmaceuticals is
. -
How much funding has Tripex Pharmaceuticals raised over time?
Tripex Pharmaceuticals has raised $1.88M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »